Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in CYTK — Cytokinetics Inc

CIK 1387508 NEW YORK, NY

Position in CYTK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,437,694
-$947,534 QoQ
Shares Held
21,813
-41.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Derivatives in CYTK

reported options exposure · as of Jun 30, 2024
CallValue
$222,138
CallShares
4,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CYTK

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,437,694 21,813
2025-12-31 $2,385,228 37,539
2025-09-30 $2,279,575 41,477
2025-06-30 $1,172,953 35,501
2025-03-31 $1,147,585 28,554
2024-12-31 $950,490 20,206
2024-09-30 $997,444 18,891
2024-06-30 $222,138 4,100
2024-03-31 $1,123,372 16,023
2024-03-31 $280,440 4,000
2023-12-31 $984,013 11,786
2023-09-30 $285,762 9,700
2023-06-30 $295,830 9,069
2023-03-31 $256,957 7,302
2020-09-30 $401,910 18,564
2020-09-30 $19,485 900
2020-06-30 $261,697 11,103
2020-03-31 $29,109 2,469